1) uretoinime
脲酮亚胺
1.
A series liquefied MDI (carbodiimide modified MDI) containing different amount of carbodiimide and uretoinime were synthesized by controlling carbodiimide conversion, samples were analysized by gel chromatogram, by the same time, all peaks in GPC spectrum were detected and determined their corresponding component by infrared spectrum.
液化MDI是MDI类异氰酸酯的重要品种之一 ,通过控制碳化二亚胺转化率可合成具有不同含量碳化二亚胺、脲酮亚胺等官能团的碳化二亚胺改性MDI,采用凝胶色谱法 (GPC)分析产品 ,同时辅以红外光谱 (IR)检测确定凝胶色谱谱图中各个峰对应组
2) polyureao-imide
聚脲酰亚胺
3) poly(imino ketone)
聚亚胺酮
1.
Novel poly(imino ketone)(PIK) was synthesized via palladium catalyzed polycondensation reaction.
以二溴化芳香酮和芳香二胺为单体,通过钯催化的胺化缩聚反应合成了新型聚合物——聚亚胺酮,其结构经1HNMR,IR和元素分析确认。
2.
1,4-Bis-(4-bromobenzoyl)benzene as the monomer of poly(imino ketone) was synthesized by Friedel-Crafts benzoylation reaction.
通过傅-克酰基化反应合成了1,4-双-(4′-溴苯酰基)苯,以1,4-双-(4′-溴苯酰基)苯和4′4-二氨基二苯醚为单体,通过钯催化的胺基化缩聚反应合成了高性能聚合物——聚亚胺酮-Ⅱ(PIK-Ⅱ)。
3.
Novel poly(imino ketone) s (PIKs) as high performance polymers were obtained by the condensation polymerization of 1,4-bis-(4-bromobenzoyl)benzene and aromatic diamines as the monomers via palladium-catalyzed amination reaction.
以1,4-双-(4′-溴苯酰基)苯和芳香二胺为单体,通过钯催化的胺基化反应缩聚合成了新型高性能聚合物——聚亚胺酮(PIKs)。
4) poly(imino ketone)s
聚亚胺酮
1.
Synthesis and properties of Poly(imino ketone)sas high-performance polymers;
新型高性能材料-聚亚胺酮(PIKs)的合成与性能
5) ketimine
['ki:tə,mi:n]
酮亚胺
1.
The Research on Preparation and Performance of Ketimine Curing Agent;
新型酮亚胺改性固化剂的合成及其性能研究
2.
The influeuce of charging approaches and dosage of ketimine on hardness,thickness,water resistance,acid resistance,alkali resistance,heat stability and mechanical performance of the paint film were studied.
用丙酮分别和乙二胺、己二胺反应制备酮亚胺,并以其作为潜伏性扩链剂改善水性聚氨酯(PU)的性能。
3.
It consists of four main parts of (1) study of the preparation and properties for the IPDI based waterborne polyurethane, (2) the synthesis of ketimine and modification of aqueous polyurethane, (3) modification of water-based polyurethane dispersions by polyacrylate, and (4) preparation of "living" radical macromolecule initiator.
本论文由四部分组成：1)IPDI基阴离子水性聚氨酯树脂的制备与性能研究 2)酮亚胺的制备及其对水性聚氨酯性能的改进 3)新型丙烯酸酯改性聚氨酯水性树脂的制备与性能研究 4)活性自由基聚合大分子引发剂的制备。
6) α-iminoketone
α-亚胺酮
1.
Asymmetric transfer hydrogenation of α-iminoketone methyl 5-[(1,1-dimethylethyl)- imino]acetyl-2-hydroxybenzoate (2) using chiral (S,S)-Ru-TsDPEN as catalyst, gave the optical pure β-amino-1-arylethanol derivative methyl 5-[2-[1,1-dimethylethyl]amino]-1-hydroxyethyl]-2-hydroxyben- zoate (3), which was reduced to afford (R)-(-)-salbutamol.
用手性(S,S)-Ru-TsDPEN催化剂不对称转移氢化α-亚胺酮化合物5-[(1,1-二甲基乙基)亚胺基]乙酰基-2-羟基苯甲酸甲酯(2)得光学纯β-氨基芳基乙醇类化合物(R)-5-[2-[(1,1-二甲基乙基)氨基]-1-羟乙基]-2-羟基苯甲酸甲酯(3),再经一步还原反应即得(R)-(-)-沙丁胺醇。
补充资料：丙二胺亚胺,丙二胺四乙酰亚胺
分子式：
CAS号：
性质：又名丙二胺亚胺，丙二胺四乙酰亚胺，抗癌-173。为白色粉末，溶于热水，酸中稳定，碱中不稳定。由哌嗪二酮制取。适用于急性白血病、恶性淋巴瘤、肺癌、肝癌、胃癌、肾癌和软组织肉瘤术后预防远处转移，特别是肺转移的发生。制剂为片剂。
CAS号：
性质：又名丙二胺亚胺，丙二胺四乙酰亚胺，抗癌-173。为白色粉末，溶于热水，酸中稳定，碱中不稳定。由哌嗪二酮制取。适用于急性白血病、恶性淋巴瘤、肺癌、肝癌、胃癌、肾癌和软组织肉瘤术后预防远处转移，特别是肺转移的发生。制剂为片剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条